Efflux pump-mediated drug resistance in burkholderia

Frontiers in Microbiology

Volumn 6, Issue MAR, 2015, Pages 1-25

  Podnecky, Nicole L ^b,c   Rhodes, Katherine A ^a,b   Schweizer, Herbert P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Veterinary Dentistry and Oral Surgery   (United States)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Adaptation; Antibiotics; Burkholderia; Efflux pump; Resistance

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; TOBRAMYCIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BIOINFORMATICS; BURKHOLDERIA; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA VIETNAMIENSIS; CYSTIC FIBROSIS; EFFLUX PUMP; GENE EXPRESSION; HUMAN; MELIOIDOSIS; MEMBRANE BIOLOGY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; QUORUM SENSING; UPREGULATION;

ACINETOBACTER BAUMANNII; BURKHOLDERIA; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA THAILANDENSIS; BURKHOLDERIA VIETNAMIENSIS; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 84927169367     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00305     Document Type: Article

References (109)

1. Aendekerk, S., Diggle, S.P., Song, Z., Hoiby, N., Cornelis, P., Williams, P., and Camara, M. (2005). The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cellto- cell communication. Microbiology 151, 1113-1125.
2. Agnoli, K., Schwager, S., Uehlinger, S., Vergunst, A., Viteri, D.F., Nguyen, D.T., Sokol, P.A., Carlier, A., and Eberl, L. (2012). Exposing the third chromosome of Burkholderia cepacia complex strains as a virulence plasmid. Mol Microbiol 83, 362-378.
3. Bazzini, S., Udine, C., and Riccardi, G. (2011a). Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium. Appl Microbiol Biotechnol 92, 887-895.
4. Bazzini, S., Udine, C., Sass, A., Pasca, M.R., Longo, F., Emiliani, G., Fondi, M., Perrin, E., Decorosi, F., Viti, C., Giovannetti, L., Leoni, L., Fani, R., Riccardi, G., Mahenthiralingam, E., and Buroni, S. (2011b). Deciphering the role of RND efflux transporters in Burkholderia cenocepacia. PLoS One 6, e18902. doi: 10.1371/journal.pone.0018902
5. Bianco, N., Neshat, S., and Poole, K. (1997). Conservation of the multidrug resistance efflux gene oprM in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41, 853-856.
6. Biot, F.V., Lopez, M.M., Poyot, T., Neulat-Ripoll, F., Lignon, S., Caclard, A., Thibault, F.M., Peinnequin, A., Pages, J.M., and Valade, E. (2013). Interplay between three RND efflux pumps in doxycycline-selected strains of Burkholderia thailandensis. PLoS One 8, e84068. doi: 10.1371/journal.pone.0084068
7. Biot, F.V., Valade, E., Garnotel, E., Chevalier, J., Villard, C., Thibault, F.M., Vidal, D.R., and Pages, J.M. (2011). Involvement of the efflux pumps in chloramphenicol selected strains of Burkholderia thailandensis: proteomic and mechanistic evidence. PLoS One 6, e16892. doi: 10.1371/journal.pone.0016892
8. Brett, P.J., Deshazer, D., and Woods, D.E. (1998). Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Int. J. Syst. Bacteriol. 48, 317-320.
9. Burns, J. (2007). "Antibiotic resistance of Burkholderia spp.," in Burkholderia Molecular Microbiology and Genomics, eds. T. Coenye & P. Vandamme. (Norfolk, UK: Horizon Bioscience), 81-91.
10. Burns, J.L., Wadsworth, C.D., Barry, J.J., and Goodall, C.P. (1996). Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob Agents Chemother 40, 307-313.
11. Buroni, S., Matthijs, N., Spadaro, F., Van Acker, H., Scoffone, V.C., Pasca, M.R., Riccardi, G., and Coenye, T. (2014). Differential roles of RND efflux pumps in antimicrobial drug resistance of sessile and planktonic Burkholderia cenocepacia cells. Antimicrob Agents Chemother 58, 7424-7429.
12. Buroni, S., Pasca, M.R., Flannagan, R.S., Bazzini, S., Milano, A., Bertani, I., Venturi, V., Valvano, M.A., and Riccardi, G. (2009). Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance. BMC Microbiol 9, 200. doi:10.1186/1471-2180-9-200
13. Campos, C.G., Borst, L., and Cotter, P.A. (2013). Characterization of BcaA, a putative classical autotransporter protein in Burkholderia pseudomallei. Infect Immun 81, 1121-1128.
14. Chan, Y.Y., Bian, H.S., Tan, T.M., Mattmann, M.E., Geske, G.D., Igarashi, J., Hatano, T., Suga, H., Blackwell, H.E., and Chua, K.L. (2007a). Control of quorum sensing by a Burkholderia pseudomallei multidrug efflux pump. J Bacteriol 189, 4320-4324.
15. Chan, Y.Y., and Chua, K.L. (2005). The Burkholderia pseudomallei BpeAB-OprB efflux pump: expression and impact on quorum sensing and virulence. J. Bacteriol. 187, 4707-4719.
16. Chan, Y.Y., and Chua, K.L. (2010). Growth-related changes in intracellular spermidine and its effect on efflux pump expression and quorum sensing in Burkholderia pseudomallei. Microbiology 156, 1144-1154.
17. Chan, Y.Y., Ong, Y.M., and Chua, K.L. (2007b). Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei. Antimicrob Agents Chemother 51, 623-630.
18. Chan, Y.Y., Tan, T.M.C., Ong, Y.M., and Chua, K.L. (2004). BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei. Antimicrob. Agents Chemother. 48, 1128-1135.
19. Cheng, A.C., Dance, D.A., and Currie, B.J. (2005). Bioterrorism, Glanders and melioidosis. Euro Surveill 10, E1-2; author reply E1-2.
20. Coenye, T., Van Acker, H., Peeters, E., Sass, A., Buroni, S., Riccardi, G., and Mahenthiralingam, E. (2011). Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms. Antimicrob Agents Chemother 55, 1912-1919.
21. Cummings, J.E., Beaupre, A.J., Knudson, S.E., Liu, N., Yu, W., Neckles, C., Wang, H., Khanna, A., Bommineni, G.R., Trunck, L.A., Schweizer, H.P., Tonge, P.J., and Slayden, R.A. (2014). Substituted diphenyl ethers as a novel chemotherapeutic platform against Burkholderia pseudomallei. Antimicrob Agents Chemother 58, 1646-1651.
22. Currie, B.J., Ward, L., and Cheng, A.C. (2010). The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis 4, e900. doi: 10.1371/journal.pntd.0000900
23. Drevinek, P., and Mahenthiralingam, E. (2010). Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infect 16, 821-830.
24. Dubarry, N., Du, W., Lane, D., and Pasta, F. (2010). Improved electrotransformation and decreased antibiotic resistance of the cystic fibrosis pathogen Burkholderia cenocepacia strain J2315. Appl Environ Microbiol 76, 1095-1102.
25. Evans, K., Passador, L., Srikumar, R., Tsang, E., Nezezon, J., and Poole, K. (1998). Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa. J Bacteriol 180, 5443-5447.
26. Fehlner-Gardiner, C.C., and Valvano, M.A. (2002). Cloning and characterization of the Burkholderia vietnamensis norM gene encoding a multi-drug efflux system. FEMS Microbiol Lett 215, 279-283.
27. Fujisaki, S., Ohnuma, S., Horiuchi, T., Takahashi, I., Tsukui, S., Nishimura, Y., Nishino, T., Kitabatake, M., and Inokuchi, H. (1996). Cloning of a gene from Escherichia coli that confers resistance to fosmidomycin as a consequence of amplification. Gene 175, 83-87.
28. Gamberi, T., Rocchiccioli, S., Papaleo, M., Magherini, F., Citti, L., Buroni, S., Bazzini, S., Udine, C., Perrin, E., Modesti, M., and Fani, R. (2013). RND-4 efflux transporter gene deletion in Burkholderia cenocepacia J2315: a proteomic analysis. J Proteome Sci Comp Biol 2. doi: 10.7243/2050-2273-2-1
29. Glass, M.B., Gee, J.E., Steigerwalt, A.G., Cavuoti, D., Barton, T., Hardy, R.D., Godoy, D., Spratt, B.G., Clark, T.A., and Wilkins, P.P. (2006). Pneumonia and septicemia caused by Burkholderia thailandensis in the United States. J Clin Microbiol 44, 4601-4604.
30. Golini, G., Favari, F., Marchetti, F., and Fontana, R. (2004). Bacteriostatic and bactericidal activity of levofloxacin against clinical isolates from cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 23, 798-800.
31. Grove, A. (2010). Urate-responsive MarR homologs from Burkholderia. Mol Biosyst 6, 2133-2142.
32. Guglierame, P., Pasca, M.R., De Rossi, E., Buroni, S., Arrigo, P., Manina, G., and Riccardi, G. (2006). Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome. BMC Microbiol 6, 66. doi: 10.1186/1471-2180-6-66.
33. Hamad, M.A., Skeldon, A.M., and Valvano, M.A. (2010). Construction of aminoglycosidesensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay. Appl Environ Microbiol 76, 3170-3176.
34. Hancock, R.E.W. (1998). Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative bacteria. Clin. Infect. Dis. 27 (Suppl 1), S93-S99.
35. Hayashi, S., Abe, M., Kimoto, M., Furukawa, S., and Nakazawa, T. (2000). The dsbA-dsbB disulfide bond formation system of Burkholderia cepacia is involved in the production of protease and alkaline phosphatase, motility, metal resistance, and multi-drug resistance. Microbiol Immunol 44, 41-50.
36. Hayden, H.S., Lim, R., Brittnacher, M.J., Sims, E.H., Ramage, E.R., Fong, C, Wu, Z., Crist, E., Chang, J., Zhou, Y., Radey, M., Rohmer, L., Haugen, E., Gillett, W., Wuthiekanun, V., Peacock, S.J., Kaul, R., Miller, S.I., Manoil, C, and Jacobs, M.A. (2012). Evolution of Burkholderia pseudomallei in recurrent melioidosis. PLoS One 7, e36507. doi: 10.1371/journal.pone.0036507
37. Hemsley, CM., Luo, J.X., Andreae, C.A., Butler, C.S., Soyer, O.S., and Titball, R.W. (2014). Bacterial drug tolerance under clinical conditions is governed by anaerobic adaptation but not anaerobic respiration. Antimicrob Agents Chemother 58, 5775-5783.
38. Hirakata, Y., Kondo, A., Hoshino, K., Yano, H., Arai, K., Hirotani, A., Kunishima, H., Yamamoto, N., Hatta, M., Kitagawa, M., Kohno, S., and Kaku, M. (2009). Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa. Int J Antimicrob Agents 34, 343-346.
39. Holden, M.T., Seth-Smith, H.M., Crossman, L.C., Sebaihia, M., Bentley, S.D., Cerdeno-Tarraga, A.M., Thomson, N.R., Bason, N., Quail, M.A., Sharp, S., Cherevach, I., Churcher, C, Goodhead, I., Hauser, H., Holroyd, N., Mungall, K., Scott, P., Walker, D., White, B., Rose, H., Iversen, P., Mil-Homens, D., Rocha, E.P., Fialho, A.M., Baldwin, A., Dowson, C, Barrell, B.G., Govan, J.R., Vandamme, P., Hart, C.A., Mahenthiralingam, E., and Parkhill, J. (2009). The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol 191, 261-277.
40. Holden, M.T.G., Titball, R.W., Peacock, S.J., Cerdeno-Tarraga, A.M., Atkins, T.P., Crossman, L.C., Pitt, T.L., Churcher, C, Mungall, K.L., Bentley, S.D., Sebaihia, M., Thomson, N.R., Bason, N., Beacham, I.R., Brooks, K., Brown, K.A., Brown, N.F., Challis, G.L., Cherevach, I., Chillingworth, T., Cronin, A., Crossett, B., Davis, P., Deshazer, D., Feltwell, T., Fraser, A., Hance, Z., Hauser, H., Holroyd, S., Jagels, K., Keith, K.E., Maddison, M., Moule, S., Price, C, Quail, M.A., Rabbinowitsch, E., Rutherford, K., Sanders, M., Simmonds, M., Songsivilai, S., Stevens, K., Tumapa, S., Vesaratchavest, M., Whitehead, S., Yeats, C., Barrell, B.G., Oyston, P.C.F., and Parkhill, J. (2004). Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci USA 101, 14240-14245.
41. Holland, D.J., Wesley, A., Drinkovic, D., and Currie, B.J. (2002). Cystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem? Clin Infect Dis 35, e138-140.
42. Jassem, A.N., Forbes, C.M., and Speert, D.P. (2014). Investigation of aminoglycoside resistance inducing conditions and a putative AmrAB-OprM efflux system in Burkholderia vietnamiensis. Ann Clin Microbiol Antimicrob 13, 2.
43. Jassem, A.N., Zlosnik, J.E., Henry, D.A., Hancock, R.E., Ernst, R.K., and Speert, D.P. (2011). In vitro susceptibility of Burkholderia vietnamiensis to aminoglycosides. Antimicrob Agents Chemother 55, 2256-2264.
44. Kang, Y., Carlson, R., Tharpe, W., and Schell, M.A. (1998). Characterization of genes involved in biosynthesis of a novel antibiotic from Burkholderia cepacia BC11 and their role in biological control of Rhizoctonia solani. Appl Environ Microbiol 64, 3939-3947.
45. Koehler, T., Michea-Hamzehpour, M., Henze, U., Gotoh, N., Curty, L.K., and Pechere, J.C. (1997). Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol 23, 345-354.
46. Koehler, T., Van Delden, C., Kocjanic Curty, L., Hamzehpour, M.M., and Pechere, J.-C. (2001). Overexpression of the MexEF-OprN multidrug efflux system affects cell-to cell signaling in Pseudomonas aeruginosa. J Bacteriol 183, 5213-5222.
47. Kumar, A., Chua, K.-L., and Schweizer, H.P. (2006). Method for regulated expression of singlecopy efflux pump genes in a surrogate Pseudomonas aeruginosa strain: identification of the BpeEF-OprC chloramphenicol and trimethoprim efflux pump of Burkholderia pseudomallei 1026b. Antimicrob Agents Chemother 50, 3460-3463.
48. Kumar, A., Mayo, M., Trunck, L.A., Cheng, A.C., Currie, B.J., and Schweizer, H.P. (2008). Expression of resistance-nodulation-cell division efflux pumps in commonly used Burkholderia pseudomallei strains and clinical isolates from Northern Australia. Trans Roy Soc Trop Med Hyg 102/S1, S145-S151.
49. Li, X.Z., Nikaido, H., and Poole, K. (1995). Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39, 1948-1953.
50. Liu, H., Ibrahim, M., Qiu, H., Kausar, S., Ilyas, M., Cui, Z., Hussain, A., Li, B., Waheed, A., Zhu, B., and Xie, G. (2015). Protein profiling analyses of the outer membrane of Burkholderia cenocepacia reveal a niche-specific proteome. Microb Ecol 69, 75-83.
51. Liu, N., Cummings, J.E., England, K., Slayden, R.A., and Tonge, P.J. (2011). Mechanism and inhibition of the FabI enoyl-ACP reductase from Burkholderia pseudomallei. J Antimicrob Chemother 66, 564-573.
52. Losada, L., Ronning, C.M., Deshazer, D., Woods, D., Fedorova, N., Kim, H.S., Shabalina, S.A., Pearson, T.R., Brinkac, L., Tan, P., Nandi, T., Crabtree, J., Badger, J., Beckstrom-Sternberg, S., Saqib, M., Schutzer, S.E., Keim, P., and Nierman, W.C. (2010). Continuing evolution of Burkholderia mallei through genome reduction and large-scale rearrangements. Genome Biol Evol 2, 102-116.
53. Loutet, S.A., and Valvano, M.A. (2011). Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia. Front Microbiol 2, 159. doi: 10.3389/fmicb.2011.00159
54. Mahenthiralingam, E., Urban, T.A., and Goldberg, J.B. (2005). The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 3, 144-156.
55. Maravic, A., Skocibusic, M., Sprung, M., Samanic, I., Puizina, J., and Pavela-Vrancic, M. (2012). Occurrence and antibiotic susceptibility profiles of Burkholderia cepacia complex in coastal marine environment. Int J Environ Health Res 22, 531-542.
56. Mcgowan, J.E., Jr. (2006). Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Infect Control 34, S29-37; discussion S64-73.
57. Messiaen, A.S., Verbrugghen, T., Declerck, C., Ortmann, R., Schlitzer, M., Nelis, H., Van Calenbergh, S., and Coenye, T. (2011). Resistance of the Burkholderia cepacia complex to fosmidomycin and fosmidomycin derivatives. Int J Antimicrob Agents 38, 261-264.
58. Mima, T., and Schweizer, H.P. (2010). The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system. Antimicrob Agents Chemother 54, 3113-3120.
59. Mima, T., Schweizer, H.P., and Xu, Z.-Q. (2011). In vitro activity of cethromycin against Burkholderia pseudomallei and investigation of mechanism of resistance. J Antimicrob Chemother 66, 73-78.
60. Mine, T., Morita, Y., Kataoka, A., Mizushima, T., and Tsuchiya, T. (1999). Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob Agents Chemother 43, 415-417.
61. Mira, N.P., Madeira, A., Moreira, A.S., Coutinho, C.P., and Sa-Correia, I. (2011). Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients' airways and antimicrobial therapy. PLoS One 6, e28831. doi: 10.1371/journal.pone.0028831
62. Moore, R.A., Deshazer, D., Reckseidler, S., Weissman, A., and Woods, D.E. (1999). Effluxmediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother 43, 465-470.
63. Morita, Y., Tomida, J., and Kawamura, Y. (2012). MexXY multidrug efflux system of Pseudomonas aeruginosa. Front Microbiol 3, 408. doi: 10.3389/fmicb.2012.00408
64. Nair, B.M., Cheung, K.J., Jr., Griffith, A., and Burns, J.L. (2004). Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J Clin Invest 113, 464-473.
65. Nair, B.M., Joachimiak, L.A., Chattopadhyay, S., Montano, I., and Burns, J.L. (2005). Conservation of a novel protein associated with an antibiotic efflux operon in Burkholderia cenocepacia. FEMS Microbiol Lett 245, 337-344.
66. Nierman, W.C., Deshazer, D., Kim, H.S., Tettelin, H., Nelson, K.E., Feldblyum, T., Ulrich, R.L., Ronning, C.M., Brinkac, L.M., Daugherty, S.C., Davidsen, T.D., Deboy, R.T., Dimitrov, G., Dodson, R.J., Durkin, A.S., Gwinn, M.L., Haft, D.H., Khouri, H., Kolonay, J.F., Madupu, R., Mohammoud, Y., Nelson, W.C., Radune, D., Romero, C.M., Sarria, S., Selengut, J., Shamblin, C., Sullivan, S.A., White, O., Yu, Y., Zafar, N., Zhou, L., and Fraser, C.M. (2004). Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci USA 101, 14246-14251.
67. Nikaido, H., and Pages, J.M. (2012). Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev 36, 340-363.
68. Nishino, K., and Yamaguchi, A. (2001). Analysis of a complete library of putative drug transporter genes in Escherichia coli. J Bacteriol 183, 5803-5812.
69. O'quinn, A.L., Wiegand, E.M., and Jeddeloh, J.A. (2001). Burkholderia pseudomallei kills the nematode Caenorhabditis elegans using an endotoxin-mediated paralysis. Cell Microbiol 3, 381-393.
70. Pearson, J.P., Van Delden, C., and Iglewski, B.H. (1999). Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals. J Bacteriol 181, 1203-1210.
71. Peeters, E., Nelis, H.J., and Coenye, T. (2009). In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria. J Antimicrob Chemother 64, 801-809.
72. Perrin, E., Fondi, M., Papaleo, M.C., Maida, I., Buroni, S., Pasca, M.R., Riccardi, G., and Fani, R. (2010). Exploring the HME and HAE1 efflux systems in the genus Burkholderia. BMC Evol Biol 10, 164. doi: 10.1186/1471-2148-10-164
73. Podin, Y., Sarovich, D.S., Price, E.P., Kaestli, M., Mayo, M., Hii, K., Ngian, H., Wong, S., Wong, I., Wong, J., Mohan, A., Ooi, M., Fam, T., Wong, J., Tuanyok, A., Keim, P., Giffard, P.M., and Currie, B.J. (2014). Burkholderia pseudomallei isolates from Sarawak, Malaysian Borneo, are predominantly susceptible to aminoglycosides and macrolides. Antimicrob Agents Chemother 58, 162-166.
74. Podnecky, N.L., Wuthiekanun, V., Peacock, S.J., and Schweizer, H.P. (2013). The BpeEF-OprC efflux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates. Antimicrob Agents Chemother 57, 4381-4386.
75. Poole, K. (2001). Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J Mol Microbiol Biotechnol 3, 255-264.
76. Poole, K., Krebes, K., Mcnally, C., and Neshat, S. (1993). Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 175, 7363-7372.
77. Price, E.P., Sarovich, D.S., Mayo, M., Tuanyok, A., Drees, K.P., Kaestli, M., Beckstrom-Sternberg, S.M., Babic-Sternberg, J.S., Kidd, T.J., Bell, S.C., Keim, P., Pearson, T., and Currie, B.J. (2013). Within-host evolution of Burkholderia pseudomallei over a twelveyear chronic carriage infection. MBio 4(4). doi: 10.1128/mBio.00388-13
78. Propst, K.L. (2011). The analysis of Burkholderia pseudomallei virulence and efficacy of potential therapeutics. PhD Dissertation, Colorado State University.
79. Propst, K.L., Mima, T., Choi, K.H., Dow, S.W., and Schweizer, H.P. (2010). A Burkholderia pseudomallei δpurM mutant is avirulent in immune competent and immune deficient animals: candidate strain for exclusion from Select Agent lists. Infect Immu. 78, 3136-3143.
80. Rajendran, R., Quinn, R.F., Murray, C., Mcculloch, E., Williams, C., and Ramage, G. (2010). Efflux pumps may play a role in tigecycline resistance in Burkholderia species. Int J Antimicrob Agents 36, 151-154.
81. Rushton, L., Sass, A., Baldwin, A., Dowson, C.G., Donoghue, D., and Mahenthiralingam, E. (2013). Key role for efflux in the preservative susceptibility and adaptive resistance of Burkholderia cepacia complex bacteria. Antimicrob Agents Chemother 57, 2972-2980.
82. Sass, A., Marchbank, A., Tullis, E., Lipuma, J.J., and Mahenthiralingam, E. (2011). Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. BMC Genomics 12, 373. doi: 10.1186/1471-2164-12-373
83. Schell, M.A., Zhao, P., and Wells, L. (2011). Outer membrane proteome of Burkholderia pseudomallei and Burkholderia mallei from diverse growth conditions. J Proteome Res 10, 2417-2424.
84. Schulin, T., and Steinmetz, I. (2001). Chronic melioidosis in a patient with cystic fibrosis. J Clin Microbiol 39, 1676-1677.
85. Schweizer, H. (2012a). "Mechanisms of Burkholderia pseudomallei antimicrobial resistance," in Melioidosis-A century of Observation and Research, ed. N. Ketheesan. Elsevier), 229-238.
86. Schweizer, H.P. (2012b). Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis. Future Microbiol 7, 1389-1399.
87. Schweizer, H.P. (2012c). When it comes to drug discovery not all Gram-negative bacterial biodefence pathogens are created equal: Burkholderia pseudomallei is different. Microb Biotechnol 5, 581-583.
88. Scoffone, V.C., Spadaro, F., Udine, C., Makarov, V., Fondi, M., Fani, R., De Rossi, E., Riccardi, G., and Buroni, S. (2014). Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia. Antimicrob Agents Chemother 58, 2415-2417.
89. Scott, A.E., Laws, T.R., D'elia, R.V., Stokes, M.G., Nandi, T., Williamson, E.D., Tan, P., Prior, J.L., and Atkins, T.P. (2013). Protection against experimental melioidosis following immunization with live Burkholderia thailandensis expressing a manno-heptose capsule. Clin Vaccine Immunol 20, 1041-1047.
90. Sim, B.M., Chantratita, N., Ooi, W.F., Nandi, T., Tewhey, R., Wuthiekanun, V., Thaipadungpanit, J., Tumapa, S., Ariyaratne, P., Sung, W.K., Sem, X.H., Chua, H.H., Ramnarayanan, K., Lin, C.H., Liu, Y., Feil, E.J., Glass, M.B., Tan, G., Peacock, S.J., and Tan, P. (2010). Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates. Genome Biol 11, R89. doi: 10.1186/gb-2010-11-8-r89
91. Simpson, A.J., Newton, P.N., Chierakul, W., Chaowagul, W., and White, N.J. (2003). Diabetes mellitus, insulin, and melioidosis in Thailand. Clin Infect Dis 36, e71-72.
92. Sobel, M.L., Mckay, G.A., and Poole, K. (2003). Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 47, 3202-3207.
93. Song, H., Hwang, J., Yi, H., Ulrich, R.L., Yu, Y., Nierman, W.C., and Kim, H.S. (2010). The early stage of bacterial genome-reductive evolution in the host. PLoS Pathog 6, e1000922. doi: 10.1371/journal.ppat.1000922
94. Tegos, G.P., Haynes, M.K., and Schweizer, H.P. (2012). Dissecting novel virulent determinants in the Burkholderia cepacia complex. Virulence 3, 234-237.
95. Teng, M., Hilgers, M.T., Cunningham, M.L., Borchardt, A., Locke, J.B., Abraham, S., Haley, G., Kwan, B.P., Hall, C., Hough, G.W., Shaw, K.J., and Finn, J. (2013). Identification of bacteria-selective threonyl-tRNA synthetase substrate inhibitors by structure-based design. J Med Chem 56, 1748-1760.
96. Tian, Z.X., Mac Aogain, M., O'connor, H.F., Fargier, E., Mooij, M.J., Adams, C., Wang, Y.P., and O'gara, F. (2009). MexT modulates virulence determinants in Pseudomonas aeruginosa independent of the MexEF-OprN efflux pump. Microb Pathog 47, 237-241.
97. Trunck, L.A., Propst, K.L., Wuthiekanun, V., Tuanyok, A., Beckstrom-Sternberg, S.M., Beckstrom-Sternberg, J.S., Peacock, S.J., Keim, P., Dow, S.W., and Schweizer, H.P. (2009). Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand. PLoS Negl Trop Dis 3, e0000519. doi: 10.1371/journal.pntd.0000519
98. Tseng, S.P., Tsai, W.C., Liang, C.Y., Lin, Y.S., Huang, J.W., Chang, C.Y., Tyan, Y.C., and Lu, P.L. (2014). The contribution of antibiotic resistance mechanisms in clinical Burkholderia cepacia complex isolates: an emphasis on efflux pump activity. PLoS One 9, e104986. doi: 10.1371/journal.pone.0104986
99. Vandamme, P., and Dawyndt, P. (2011). Classification and identification of the Burkholderia cepacia complex: Past, present and future. Syst Appl Microbiol 34, 87-95.
100. Vanlaere, E., Baldwin, A., Gevers, D., Henry, D., De Brandt, E., Lipuma, J.J., Mahenthiralingam, E., Speert, D.P., Dowson, C., and Vandamme, P. (2009). Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol 59, 102-111.
101. Viktorov, D.V., Zakharova, I.B., Podshivalova, M.V., Kalinkina, E.V., Merinova, O.A., Ageeva, N.P., Antonov, V.A., Merinova, L.K., and Alekseev, V.V. (2008). High-level resistance to fluoroquinolones and cephalosporins in Burkholderia pseudomallei and closely related species. Trans R Soc Trop Med Hyg 102 Suppl 1, S103-110.
102. Vora, S.K. (2002). Sherlock Holmes and a biological weapon. J R Soc Med 95, 101-103.
103. Whitlock, G.C., Estes, D.M., and Torres, A.G. (2007). Glanders: off to the races with Burkholderia mallei. FEMS Microbiol Lett 277, 115-122.
104. Wiersinga, W.J., Birnie, E., Weehuizen, T.A., Alabi, A.S., Huson, M.A., In 'T Veld, R.A., Mabala, H.K., Adzoda, G.K., Raczynski-Henk, Y., Esen, M., Lell, B., Kremsner, P.G., Visser, C.E., Wuthiekanun, V., Peacock, S.J., Van Der Ende, A., Limmathurotsakul, D., and Grobusch, M.P. (2015). Clinical, environmental, and serologic surveillance studies of melioidosis in Gabon, 2012-2013. Emerg Infect Dis 21, 40-47.
105. Wiersinga, W.J., Currie, B.J., and Peacock, S.J. (2012). Melioidosis. N Engl J Med 367, 1035-1044.
106. Wiersinga, W.J., Van Der Poll, T., White, N.J., Day, N.P., and Peacock, S.J. (2006). Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. 4, 272-282.
107. Wigfield, S.M., Rigg, G.P., Kavari, M., Webb, A.K., Matthews, R.C., and Burnie, J.P. (2002). Identification of an immunodominant drug efflux pump in Burkholderia cepacia. J Antimicrob Chemother 49, 619-624.
108. Winsor, G.L., Khaira, B., Van Rossum, T., Lo, R., Whiteside, M.D., and Brinkman, F.S.L. (2008). The Burkholderia Genome Database: facilitating flexible queries and comparative analyses. Bioinformatics 24, 2803-2804.
109. Zhang, L., Li, X.Z., and Poole, K. (2001). Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia. J Antimicrob Chemother 48, 549-552.